Pharmaniaga to collaborate with NIBM on vaccine R&D

KUALA LUMPUR: Pharmaniaga Bhd's wholly owned subsidiary Pharmaniaga Research Centre Sdn Bhd has entered into a memorandum of understanding with the National Institutes of Biotechnology Malaysia (NIBM) to collaborate on vaccine research and development.

It said in a filing with Bursa Malaysia that the MoU shall come into effect from Nov 1, 2021, and shall remain in force for a period of three years or until termination of the MoU, whichever is earlier.